8-K
Current Report
Cocrystal Pharma, Inc. Filed Acc 0001521536-13-000295
Material agreement · New debt or obligation
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading q1101046_8k-biozone.htm…